Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
25
0.580
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
997
0.510
 Why?
Leukemia, Myeloid, Acute
4
2010
180
0.400
 Why?
Osteosarcoma
2
2016
45
0.330
 Why?
von Willebrand Diseases
1
2009
22
0.320
 Why?
Hematology
1
2009
27
0.310
 Why?
Sclerotherapy
2
2020
46
0.310
 Why?
Antineoplastic Agents
5
2016
1165
0.290
 Why?
Vascular Malformations
2
2020
102
0.280
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.280
 Why?
Hemophilia B
1
2007
5
0.280
 Why?
Hemostasis, Surgical
1
2007
11
0.280
 Why?
Blood Coagulation Factors
1
2007
17
0.270
 Why?
Enoxaparin
1
2007
31
0.270
 Why?
Child, Preschool
13
2020
3953
0.270
 Why?
Blood Loss, Surgical
1
2007
67
0.270
 Why?
Venous Thrombosis
1
2007
86
0.250
 Why?
Cisplatin
3
2016
283
0.250
 Why?
Cyclosporine
1
2005
67
0.240
 Why?
Blood Coagulation Disorders
2
2020
38
0.240
 Why?
Leukemia
1
2005
65
0.240
 Why?
Hemostasis
2
2020
59
0.230
 Why?
Cladribine
1
2004
3
0.230
 Why?
Bone Regeneration
2
2016
68
0.230
 Why?
Histiocytosis, Langerhans-Cell
1
2004
31
0.220
 Why?
Retinoblastoma
1
2003
15
0.210
 Why?
Retinal Neoplasms
1
2003
13
0.210
 Why?
Infant
11
2018
3648
0.210
 Why?
Neoplasms
3
2012
1248
0.210
 Why?
Neoplasms, Second Primary
1
2003
74
0.200
 Why?
Child
14
2020
6931
0.190
 Why?
Bone Neoplasms
1
2003
178
0.180
 Why?
Thrombelastography
1
2020
25
0.170
 Why?
Adolescent
11
2020
6453
0.170
 Why?
Bleomycin
1
2018
34
0.140
 Why?
Down Syndrome
3
2008
90
0.140
 Why?
Antibiotics, Antineoplastic
1
2018
77
0.140
 Why?
Osteogenesis, Distraction
2
2016
78
0.140
 Why?
Piperazines
2
2016
120
0.130
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
6
0.130
 Why?
Humans
21
2020
50419
0.130
 Why?
Leukemia, Myeloid
2
2008
44
0.130
 Why?
Disease-Free Survival
5
2010
439
0.120
 Why?
Male
13
2020
25866
0.120
 Why?
Imidazoles
1
2016
125
0.120
 Why?
Remission Induction
4
2011
208
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
82
0.120
 Why?
Leukocyte Count
2
2005
71
0.110
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
38
0.110
 Why?
Survival Analysis
4
2010
658
0.100
 Why?
Doxorubicin
2
2005
235
0.100
 Why?
Cord Blood Stem Cell Transplantation
1
2011
6
0.090
 Why?
Sarcoma, Myeloid
1
2011
20
0.090
 Why?
Neutropenia
1
2012
116
0.090
 Why?
Heart Neoplasms
1
2011
32
0.090
 Why?
Treatment Outcome
7
2018
5265
0.090
 Why?
Core Binding Factors
1
2010
2
0.080
 Why?
Proto-Oncogene Proteins c-kit
1
2010
33
0.080
 Why?
Female
10
2020
27053
0.080
 Why?
Entamoebiasis
1
2009
2
0.080
 Why?
Diarrhea, Infantile
1
2009
4
0.080
 Why?
Listeriosis
1
2009
6
0.080
 Why?
Liver Abscess
1
2009
5
0.080
 Why?
Anemia, Aplastic
1
2009
11
0.080
 Why?
Platelet Transfusion
1
2009
29
0.080
 Why?
Histocompatibility Testing
1
2008
12
0.080
 Why?
Acute Lung Injury
1
2009
26
0.080
 Why?
Young Adult
5
2020
4075
0.080
 Why?
HLA Antigens
1
2008
52
0.070
 Why?
Abdominal Pain
1
2009
82
0.070
 Why?
Hospitals, Pediatric
1
2009
234
0.070
 Why?
Retrospective Studies
6
2018
6274
0.070
 Why?
Bone Marrow Transplantation
1
2008
135
0.070
 Why?
Adult
7
2020
13561
0.070
 Why?
Infusions, Intravenous
2
2004
212
0.070
 Why?
Cardiomyopathies
1
2008
119
0.070
 Why?
Mitolactol
1
2005
2
0.060
 Why?
GATA1 Transcription Factor
1
2005
7
0.060
 Why?
Karyotyping
1
2005
65
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2006
831
0.060
 Why?
Tamoxifen
1
2005
61
0.060
 Why?
Heart
1
2008
341
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
46
0.060
 Why?
Immunosuppressive Agents
1
2005
227
0.050
 Why?
Proto-Oncogene Proteins
1
2004
150
0.050
 Why?
Humerus
1
2003
18
0.050
 Why?
Arkansas
1
2009
1974
0.050
 Why?
Mutation
2
2010
1275
0.050
 Why?
Tibia
1
2003
119
0.050
 Why?
Methotrexate
1
2003
76
0.050
 Why?
Survivors
1
2003
126
0.050
 Why?
Topotecan
1
2002
17
0.050
 Why?
Automation
1
2002
17
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
386
0.040
 Why?
Blood Coagulation Tests
1
2020
20
0.040
 Why?
Dose-Response Relationship, Drug
1
2004
1369
0.040
 Why?
Blood Flow Velocity
1
2020
99
0.040
 Why?
Blood Coagulation
1
2020
59
0.040
 Why?
Prognosis
3
2012
1974
0.040
 Why?
Follow-Up Studies
2
2018
2231
0.040
 Why?
Mice, Inbred C57BL
2
2016
1796
0.040
 Why?
Gene Expression Profiling
1
2004
1020
0.040
 Why?
Hemorrhage
1
2020
195
0.040
 Why?
Daunorubicin
2
2008
11
0.030
 Why?
Cytarabine
2
2006
37
0.030
 Why?
Mice, Nude
1
2016
247
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
210
0.030
 Why?
Random Allocation
1
2016
284
0.030
 Why?
Acute Disease
2
2008
374
0.030
 Why?
Cluster Analysis
2
2005
209
0.030
 Why?
Prospective Studies
2
2012
2378
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
400
0.030
 Why?
Interleukin-3
1
2012
13
0.020
 Why?
Calcitonin Gene-Related Peptide
1
2012
23
0.020
 Why?
Protein Precursors
1
2012
43
0.020
 Why?
Calcitonin
1
2012
30
0.020
 Why?
Sensitivity and Specificity
2
2006
855
0.020
 Why?
Interleukin-8
1
2012
85
0.020
 Why?
Interleukin-10
1
2012
84
0.020
 Why?
ROC Curve
1
2012
223
0.020
 Why?
Fatal Outcome
1
2011
197
0.020
 Why?
Mice, Knockout
1
2013
840
0.020
 Why?
Interleukin-6
1
2012
261
0.020
 Why?
Intensive Care Units
1
2012
228
0.020
 Why?
Animals
2
2016
13063
0.020
 Why?
Pilot Projects
1
2012
694
0.020
 Why?
Exons
1
2010
94
0.020
 Why?
Time Factors
2
2008
2933
0.020
 Why?
Opportunistic Infections
1
2009
58
0.020
 Why?
Echocardiography
1
2011
398
0.020
 Why?
Translocation, Genetic
1
2010
236
0.020
 Why?
Mitoxantrone
1
2008
8
0.020
 Why?
Hospitalization
1
2012
677
0.020
 Why?
Proportional Hazards Models
1
2008
416
0.020
 Why?
Recurrence
1
2008
657
0.020
 Why?
Genetic Predisposition to Disease
1
2010
507
0.020
 Why?
Prevalence
1
2010
967
0.020
 Why?
Immunophenotyping
1
2006
106
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1163
0.020
 Why?
Luciferases
1
2005
47
0.020
 Why?
Nucleic Acid Hybridization
1
2005
56
0.020
 Why?
Diagnosis, Differential
1
2009
1029
0.020
 Why?
Cell Membrane
1
2006
247
0.020
 Why?
DNA Primers
1
2005
205
0.020
 Why?
Middle Aged
1
2020
12579
0.020
 Why?
Transfection
1
2005
353
0.010
 Why?
Tumor Cells, Cultured
1
2005
453
0.010
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.010
 Why?
fms-Like Tyrosine Kinase 3
1
2004
16
0.010
 Why?
Magnetic Resonance Imaging
1
2011
1546
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
568
0.010
 Why?
Benzamides
1
2004
50
0.010
 Why?
Risk Assessment
1
2008
1268
0.010
 Why?
Risk Factors
1
2012
3712
0.010
 Why?
Mice
1
2013
5659
0.010
 Why?
Pyrimidines
1
2004
187
0.010
 Why?
Nuclear Proteins
1
2004
235
0.010
 Why?
DNA Helicases
1
2004
147
0.010
 Why?
DNA-Binding Proteins
1
2004
410
0.010
 Why?
Predictive Value of Tests
1
2004
924
0.010
 Why?
Drug Administration Schedule
1
2002
373
0.010
 Why?
Linear Models
1
2002
283
0.010
 Why?
Neutrophils
1
2002
142
0.010
 Why?
Analysis of Variance
1
2002
549
0.010
 Why?
Transcription Factors
1
2004
561
0.010
 Why?
Patient Selection
1
2002
257
0.010
 Why?
Infant, Newborn
1
2006
2752
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (167) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department